Jun 2023 $1 M Issued in a merger or acquisition Under $2 million 6
CB3 Life Sciences Ltd.: Private sale, Jun 2023 × Investors in this round 6 investors had bought by the notice of Jun 20, 2023: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $47,366
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Saskatchewan, Canada People named in the notice Brent Zettl · Executive Officer · Chief Executive Officer Dr. Lionel Marks de Chabris · Executive Officer · Chief Medical Officer John Hyshka · Executive Officer · Chief Financial Officer Keith Carpenter · Executive Officer · Chief Strategy Officer Garnette Weber · Director John Knowles · Director Richard Hoyt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in CT, FL, MA, MO, NY Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, Missouri Sold in CT, FL, MA, MO, NY Haywood Securities (USA) Inc. (CRD 42072) · Vancouver, British Columbia, Canada Sold in CT, FL, MA, MO, NY Remarks in the notice On the amounts: “The total amount reflected in this section is based on a conversion rate of 1 USD = 1.343 CAD as of June 5 2023, and is reflective of the total offers and sales made in the U.S. only.”On a merger: “The offering was conducted in conjunction with a reverse take-over transaction between the Issuer and Phoenix Canada Oil Company Limited.”Signed by Brent Zettl, Ceo. Source: SEC Form D, newest notice filed Jun 20, 2023. Read the notice at the SEC .
equity SEC Oct 2021 $2 M No. 3 $2 to $10 million 2
CB3 Life Sciences Ltd.: Raise no. 3, Oct 2021 × Investors in this round 2 investors had bought by the notice of Nov 3, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken $100,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Saskatchewan, Canada People named in the notice Brent Zettl · Executive Officer, Director · PRESIDENT and CEO Keith Carpenter · Executive Officer · Chief Strategy and Investment Officer Rob Harding · Executive Officer · Chief Financial Officer Donald Ching · Director Garnette Weber · Director John Knowles · Director Richard Hoyt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Total Amount Sold is CAD 2,575,000 and was converted for this Form D filing to USD using the conversion rate on 11/3/21 of 1 USD = 1.24 CAD.”Signed by Brent Zettl, President and CEO. Source: SEC Form D, newest notice filed Nov 3, 2021. Read the notice at the SEC .
debt, options SEC Jul 2019 $8 M Issued in a merger or acquisition $2 to $10 million 47
CB3 Life Sciences Ltd.: Private sale, Jul 2019 × Investors in this round 47 investors had bought by the notice of Aug 13, 2019: 44 accredited, 3 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $18 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Saskatchewan, Canada People named in the notice Adam Darbellay · Executive Officer · Chief Financial Officer Brent Zettl · Executive Officer, Director · President and Chief Executive Officer Keith Carpenter · Executive Officer · Chief Strategy & Investment Officer Larry Holbrook · Executive Officer · Chief Scientific Officer Michelle Gursky · Executive Officer · VP Legal Affairs Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Additional Shares to be issued upon satisfaction of certain milestones post-merger. Original dollar amounts for offering were in CAD and were converted for this Form D filing to USD using a current conversion rate of 1 CAD = 0.76 USD.”On a merger: “The Issuer has made this offering in connection with the acquisition of Revon Systems. Inc., pursuant to a Merger Agreement and Plan of Reorganization.”Signed by Michelle Gursky, VP Legal Affairs. Source: SEC Form D, newest notice filed Aug 13, 2019. Read the notice at the SEC .
equity SEC May 2019 $2 M No. 2 $2 to $10 million 8
CB3 Life Sciences Ltd.: Raise no. 2, May 2019 × Investors in this round 8 investors had bought by the notice of May 20, 2019: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $19 M offered; $16 M still to sell
Smallest investment taken $37,125
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Saskatchewan, Canada People named in the notice Adam Darbellay · Executive Officer · CFO Brent Zettl · Executive Officer, Director · President, CEO, Secretary Keith Carpenter · Executive Officer · EVP, Strategy and M&A Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Original dollar amounts for offering were in CAD and were converted for this Form D filing to USD using a current conversion rate of 1 USD = 1.3468 CAD. The total amount sold is reflective of the amount sold in the United States.”Signed by Brent Zettl, President. Source: SEC Form D, newest notice filed May 20, 2019. Read the notice at the SEC .
equity SEC Oct 2018 $12 M No. 1 $10 to $50 million 49
CB3 Life Sciences Ltd.: Raise no. 1, Oct 2018 × Investors in this round 49 investors had bought by the notice of Oct 31, 2018: 49 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $19 M offered; $7 M still to sell
Smallest investment taken $38,092
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Saskatchewan, Canada People named in the notice Allan Fowler · Executive Officer · CFO Brent Zettl · Executive Officer, Director · President, CEO, Secretary Keith Carpenter · Executive Officer · EVP, Strategy and M&A Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Original dollar amounts for offering were in CAD and were converted for this Form D filing to USD using a current conversion rate of 1 USD = 1.31260 CAD”Signed by Brent Zettl, President. Source: SEC Form D, newest notice filed Oct 31, 2018. Read the notice at the SEC .
equity SEC